Wellington Management Group Llp

13F Holdings History for Crinetics Pharmaceuticals, Inc. - Common Stock, par value $0.001 per share (the "Shares") (CRNX)

Symbol: CRNX on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share (the "Shares")
Latest Disclosed Ownership: 5.81M shares
Security Ownership: 6.2%

Shares, Excluding Options vs Price

Value, Excluding Options

Wellington Management Group LLP ownership in Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX)

2025-08-12 - Wellington Management Group LLP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5.81M shares of Crinetics Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (the "Shares") (CRNX). This represents 6.2% percent ownership of the company. In their previous filing dated 2025-02-10, WELLINGTON MANAGEMENT GROUP LLP had reported owning 6.95M shares, indicating a decrease of -16.4% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Wellington Management Group LLP	6.2%	-16.3%	$167M	5.81M	-1,143,259	-16.4%	$28.76	13G/A	6/30/2025	12 Aug 2025 10:34:24
Wellington Management Group LLP	7.5%		$233M	6.95M			$33.54	13G/A	12/31/2024	10 Feb 2025 10:25:37

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
6/30/2025	0.03%	-0.01%	$167M	5.81M	-1,084,089	-15.7%	$28.76	Q2 2025
3/31/2025	0.04%	0%	$231M	6.89M	-59,170		$33.54	Q1 2025
12/31/2024	0.07%	+0.02%	$355M	6.95M	+2,490,876	+55.9%	$51.13	Q4 2024
9/30/2024	0.04%	0%	$228M	4.46M	-160,722	-3.48%	$51.10	Q3 2024
6/30/2024	0.04%	+0.01%	$207M	4.62M	+1,648,831	+55.5%	$44.79	Q2 2024
3/31/2024	0.02%	0%	$139M	2.97M	-273,523	-8.43%	$46.81	Q1 2024
12/31/2023	0.02%	0%	$115M	3.25M	-395,130	-10.9%	$35.58	Q4 2023
9/30/2023	0.02%	+0%	$108M	3.64M	+38,523	+1.07%	$29.74	Q3 2023
6/30/2023	0.01%	0%	$64.9M	3.6M	-33,814	-0.93%	$18.02	Q2 2023
3/31/2023	0.01%	+0%	$58.4M	3.64M	+831,041	+29.6%	$16.06	Q1 2023
12/31/2022	0.01%	+0%	$51.3M	2.8M	+171,474	+6.51%	$18.30	Q4 2022
9/30/2022	0.01%	+0%	$51.7M	2.63M	+809,413	+44.4%	$19.64	Q3 2022
6/30/2022	0.01%	+0%	$34M	1.82M	+794,234	+77.2%	$18.65	Q2 2022
3/31/2022	0%	0%	$22.6M	1.03M	-40,908	-3.82%	$21.95	Q1 2022
12/31/2021	0%	+0%	$30.4M	1.07M	+157,201	+17.2%	$28.41	Q4 2021
9/30/2021	0%	+0%	$19.2M	913K	+167,684	+22.5%	$21.05	Q3 2021
6/30/2021	0%	+0%	$14.1M	745K	+193,220	+35%	$18.85	Q2 2021
3/31/2021	0%	0%	$8.44M	552K	-4,468	-0.8%	$15.28	Q1 2021
12/31/2020	0%	+0%	$7.85M	557K	+118,879	+27.2%	$14.11	Q4 2020
9/30/2020	0%	+0%	$6.86M	438K	+126,475	+40.6%	$15.67	Q3 2020
6/30/2020	0%	+0%	$5.45M	311K	+311,281	NEW	$17.52	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.